Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Resources for You

Resources for You

                        For Industry
          For Veterinarians


                        CVM en español
          Animal Health Literacy Home
          Animal & Veterinary
          Resources for You
          Release of Client-Owned Animals When Conducting a Study to Develop Human Therapeutics Using Recombinant or Synthetic Nucleic Acid MoleculesResources for You Release of Client-Owned Animals When Conducting a Study to Develop Human Therapeutics Using Recombinant or Synthetic Nucleic Acid Molecules
  
  					Subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)
	
    Share
    Post
    Linkedin

    Email
    PrintFor research subject to the *NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)*, any animal administered recombinant or synthetic nucleic acid molecules may not be released from containment unless another Federal agency has jurisdiction over the experiment and approves the proposed release. Specifically, the *NIH Guidelines* state in Section I-A-1:

*Any nucleic acid molecule experiment, which according to the NIH Guidelines requires approval by NIH, must be submitted to NIH or to another Federal agency that has jurisdiction for review and approval. Once approvals, or other applicable clearances, have been obtained from a Federal agency other than NIH (whether the experiment is referred to that agency by NIH or sent directly there by the submitter), the experiment may proceed without the necessity for NIH review or approval.*

CVM advises that it will not object to release of animals to owners that are or were enrolled in this type of research when developing therapeutics solely for human use1 and, therefore, researchers will be considered to have the necessary “applicable clearance” for purpose of compliance with the *NIH Guidelines*, if they comply with the following conditions:

The purpose of the study is for *bona fide* scientific investigations conducted as part of exploratory, discovery, or proof-of-concept studies intended to develop human therapeutics.
	There is appropriate oversight by an Institutional Animal Care and Use Committee (IACUC), Institutional Biosafety Committee (IBC), and/or other appropriate oversight group.
	There is a protocol in place that has been reviewed and approved by the IACUC, IBC, and/or other appropriate oversight group.
	The study is limited to administering the product to up to 15 client-owned animals of nonfood-producing species.2
	The study is conducted by investigators qualified by scientific training and experience to conduct such research.
	Complete records of the investigation are maintained.
	The study is conducted at a primary location and up to 2 additional investigational sites.
	There are mitigation strategies in place to protect researchers, veterinarians, animal care takers, and other personnel that may have contact with the treated animal in regard to contact with excretions from the animal including urine, feces, and saliva, as appropriate.
	There is an informed consent form that provides the client with information on the risks to the treated animal, other animals, and the owner; appropriate and truthful safety information; and potential mitigation strategies for the owner to follow in regard to contact with excretions from the animal including urine, feces and saliva as appropriate.
	If a serious adverse event occurs during the conduct of the study, the study sponsor should inform all researchers immediately and the appropriate oversight group.
	The researcher may not charge for, recoup costs for, or market the investigational product.If a researcher believes they cannot meet one or more of these conditions, or if you have questions, please contact: AskCVM@fda.hhs.gov and put “client-owned animal study” in the subject line of the email.

Questions related to the NIH Guidelines and IBC oversight should be directed to the NIH Office of Science Policy at: NIHguidelines@od.nih.gov.

1 Contact CVM (AskCVM@fda.hhs.gov) regarding research to develop products for veterinary use.

2 If you plan to enroll more than 15 animals in a study, please contact CVM.

                                                                                  Content current as of:
      06/29/2023Resources for You

          
                        For Industry
          For Veterinarians


                        CVM en español
          Animal Health Literacy
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop